Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 6, 2023
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, and Dose-Increasing Study on the Safety, Tolerability and PK/PD of Multiple Doses of HSK7653 by Oral Administration in Patients with Type 2 Diabetes Mellitus in ChinaNan Bai, Jin Wang, Wenxin Liang, et al.Iscience|November 9, 2023
Personalized glucose-lowering effect of chiglitazar in type 2 diabetesQi Huang, Xiantong Zou, Yingli Chen, et al.Diabetes, Obesity & Metabolism|October 22, 2024
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trialLeili Gao, Fang Bian, Tianrong Pan, et al.Annals of Clinical and Translational Neurology|April 25, 2018
Diabetes and obesity are the main metabolic drivers of peripheral neuropathyBrian C Callaghan, LeiLi Gao, Yufeng Li, et al.Eclinicalmedicine|June 13, 2020
Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study)Linong Ji, Leili Gao, Liming Chen, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2024
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical StudyLinong Ji, Leili Gao, Zhikai Feng, et al.Eclinicalmedicine|October 17, 2022
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trialLinong Ji, Leili Gao, Hongwei Jiang, et al.Signal Transduction and Targeted Therapy|February 27, 2026
Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trialLinong Ji, Leili Gao, Junhang Tian, et al.Journal of Diabetes|June 13, 2023
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional studyLeili Gao, Xingwu Ran, Xuejun Liu, et al.Endocrine Connections|February 5, 2021
Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetesFang Lv, Xiaoling Cai, Chu Lin, et al.Pageof 4